The EUPATI Luxembourg NLT is a small team of four people representing the Public Research Center for Health (a public institution carrying out research with the aim to help patients) and the APL (Association Pharmaceutique Luxembourgeoise). The NLT's aim is to raise the profile of EUPATI on a country level, form a national network of stakeholders who can help disseminate information about EUPATI's education and information aimed at patient advocates, lay patients and citizens, but also generate a dialogue around future patient involvement in the medicines research and development process in their country.
The NLT is a temporary task force to drive the development and oversee the establishment of the EUPATI National Platforms (ENPs). When a critical mass of support and infrastructure is reached, the NLTs will transition into ENPs and the NLT members may or may not take on a management role within the ENP.
The consortium project "European Patients' Academy on Therapeutic Innovation" (EUPATI), funded by the Innovative Medicines Initiative, Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients, will provide scientifically reliable, objective, comprehensive information to patients on medicines research and development.
The EUPATI Luxembourg NLT is looking for a patient organisation partner to lead the team. The NLT indeed needs patient organisation’s contribution to ensure that it reaches out to the patients and the public with the right answers to their questions about medicines development.
For further information, please read this article www.luxclin.lu/Articles/Details/?c=ART1781GFV or visit the website www.eupati.org . If you are interested in joining the EUPATI Luxembourg NLT or wishes to know more about it, please contact Manon Gantenbein (email: firstname.lastname@example.org ).
Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.
Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.